Roundup: Nesa gets US FDA 510(k) for fibroid mapping tool and more briefs
Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.
Stay updated with breaking news from Nesa Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.
Get latest articles and stories on Business at LatestLY. New Delhi [India], July 26: In a major stride towards improving women's healthcare, Nesa Medtech, a prominent startup in women’s health, has announced that its groundbreaking Fibroid Mapping Reviewer Application (FMRA) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The FMRA technology represents a significant advancement that will aid physicians in planning minimally invasive image-guided treatments for uterine fibroids. Business News | Nesa Medtech Receives US FDA Clearance for Technology...